PharmacoEconomics & Outcomes News

, Volume 803, Issue 1, pp 13–13 | Cite as

Elbasvir/grazoprevir cost effective for hepatitis C in Italy

Clinical study
  • 3 Downloads

Reference

  1. Rolli FR, et al. Economic evaluation of Zepatier for the management of HCV in the Italian scenario. European Journal of Health Economics : 25 Apr 2018. Available from: URL: https://doi.org/10.1007/s10198-018-0980-4

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Personalised recommendations